NABTC CENTRAL OPERATION GRANT (UCSF PROJECT LEADER)
NABTC CENTRAL OPERATION GRANT (UCSF PROJECT LEADER)
批准号:
6341965
负责人:
MICHAEL D PRADOS
金额:
$55.78万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-03-25 至 2002-12-31
中文摘要
描述:(申请人描述)
英文摘要
DESCRIPTION: (Applicant's Description)
The Central Operations Office/Coordinating Center for this grant application
is the administrative unit that will coordinate the activities of the North
American Brain Tumor Consortium (NABTC) formed for the purpose of conducting
laboratory and clinical Phase I and II research trials for adult patients
with malignant brain tumors. The NABTC will be composed of seven treatment
centers and 1 pharmacokinetics center, and will maintain a cooperative NABTC
tissue bank. The NABTC will coordinate its efforts with the Cancer Therapy
Evaluations Program (CTEP) and the Radiation Research Program (RRP) of the
Division of Cancer Therapy to conduct novel therapies in this patient
population. The Lead Institution of the NABTC is the University of
California, San Francisco (UCSF), and the Project Leader is Michael Prados,
MD. The Central Operations Office will provide coordination of protocol d e
velopment and submissions, study conduct, quality control, protocol
performance monitoring, statistical analysis, adherence to requirements
regarding NCI drug accountability, FDA, OPRR and HHS regulations, and
protocol and institutional performance reporting. Dr Prados will be the
Principal Investigator of the Central Operations Office and thus will
coordinate the clinical and administrative actives of the NABTC in order to
achieve the NABTC goals with the assistance of CTEP. Part of these
activities will be accomplished with a subcontract with the MD Anderson
Cancer Center Data Management and Statistical Center, an operations center
that has maintained a p e er-reviewed leadership role in its participation
in consortium and intergroup studies. The end results of this NABTC Central
Operations Office will be to assure quality, verifyable, coordinated
research data that will allow ongoing rapid Phase II trials and laboratory
investigations to be conducted in the most efficient manner possible in a
patient population that thus far has little chance for survival.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PHASE I STUDY OF OSI-774 AND TEMOZOLOMIDE FOR THE TREATMENT OF GLIOMAS
-
批准号:7202618
-
项目类别:
-
资助金额:$0.42万
-
财政年份:2005
-
负责人:MICHAEL D PRADOS
-
依托单位:
NABTC 01-08: PHASE II TRIAL OF STI571 (NSC 716051) IN RECURRENT MENINGIOMA
-
批准号:7202661
-
项目类别:
-
资助金额:$0.98万
-
财政年份:2005
-
负责人:MICHAEL D PRADOS
-
依托单位:
ZD1839 FOR MALIGNANT ASTROCYTOMA OR GLIOBLASTOMA AND MENINGIOMA
-
批准号:7202621
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2005
-
负责人:MICHAEL D PRADOS
-
依托单位:
A PHASE II TRIAL OF POLY ICLC IN PATIENTS WITH RECURRENT ANAPLASTIC GLIOMA
-
批准号:7202656
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2005
-
负责人:MICHAEL D PRADOS
-
依托单位:
A Phase II Trial of Poly ICLC in Patients with Recurrent Anaplastic Glioma
-
批准号:6972317
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2004
-
负责人:MICHAEL D PRADOS
-
依托单位:
OSI-774 in Recurrent Malignant Gliomas & Malignant Gliomas Post Radiation Tx
-
批准号:6972313
-
项目类别:
-
资助金额:$0.61万
-
财政年份:2004
-
负责人:MICHAEL D PRADOS
-
依托单位:
Phase I/II trial of ST1571 in children with newly diagnosed brainstem gliomas
-
批准号:7043562
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2004
-
负责人:MICHAEL D PRADOS
-
依托单位:
Phase I/II Trial of R115777 in Patients With Recurrent Malignant Glioma
-
批准号:6972244
-
项目类别:
-
资助金额:$0.49万
-
财政年份:2004
-
负责人:MICHAEL D PRADOS
-
依托单位:
NABTC 01-08: Phase II Trial of STI571 (NSC 716051) in Recurrent Meningioma
-
批准号:6972320
-
项目类别:
-
资助金额:$0.37万
-
财政年份:2004
-
负责人:MICHAEL D PRADOS
-
依托单位:
ZD1839 for Malignant Astrocytoma or Glioblastoma and Meningioma
-
批准号:6972269
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2004
-
负责人:MICHAEL D PRADOS
-
依托单位:
ZD1839 and Temozolomide for Gliomas
-
批准号:6972270
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2004
-
负责人:MICHAEL D PRADOS
-
依托单位:
A Phase I Study of OSI-774 and Temozolomide for the Treatment of Gliomas
-
批准号:6972265
-
项目类别:
-
资助金额:$4.96万
-
财政年份:2004
-
负责人:MICHAEL D PRADOS
-
依托单位:
Adenovirus mediated wild type p53 gene therapy for gliom
-
批准号:6566751
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2001
-
负责人:MICHAEL D PRADOS
-
依托单位:
NABTC 9702--PHASE I TRIAL OF PRESURGICAL 06-BENZYLGUANINE
-
批准号:6566777
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2001
-
负责人:MICHAEL D PRADOS
-
依托单位:
PHASE II TRIAL OF TEMOZOLOMIDE & BCNU FOR MALIGNANT GLIOMAS
-
批准号:6566759
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2001
-
负责人:MICHAEL D PRADOS
-
依托单位:
Trial of irinotecan (CPT-11) in recurrent malignant glio
-
批准号:6566745
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2001
-
负责人:MICHAEL D PRADOS
-
依托单位:
PHASE II TRIAL THYMIDINE & CARBOPLATIN FOR RECURRENT MALIGNANT GLIOMA
-
批准号:6566770
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2001
-
负责人:MICHAEL D PRADOS
-
依托单位:
Adenovirus mediated wild type p53 gene therapy for gliom
-
批准号:6469280
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2000
-
负责人:MICHAEL D PRADOS
-
依托单位:
PHASE II TRIAL THYMIDINE & CARBOPLATIN FOR RECURRENT MALIGNANT GLIOMA
-
批准号:6469299
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2000
-
负责人:MICHAEL D PRADOS
-
依托单位:
PHASE II TRIAL OF TEMOZOLOMIDE & BCNU FOR MALIGNANT GLIOMAS
-
批准号:6469288
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2000
-
负责人:MICHAEL D PRADOS
-
依托单位:
海外基金